These results suggested that these three target genes (ATP4A, MCOLN1, and ATP6V0E1) can serve as effective diagnostic biomarkers for distinguishing insulinoma from NFPNET and normal islets. This evidence concerns the gene MCOLN1 and pancreatic insulinoma.